← Open Payments lookup

SAFAA KASEM: Open Payments

NPI 1023267606 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$404 in 11 payments from 5 companies in 2025. Trend: 2023 $114 · 2024 $0 · 2025 $404

Food & beverage: $377Education: $27
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$169
Axsome Therapeutics, Inc.1$119
E.R. Squibb & Sons, L.L.C.3$64
ABBVIE INC.2$33
Neurocrine BioSciences, Inc.1$20

Products named: Auvelity, ABILIFY MAINTENA, COBENFY, VRAYLAR, ABILIFY ASIMTUFII, REXULTI, INGREZZA.

Industry payments across DC — which companies pay providers there.